Previous studies suggest that HIF-1α activates pro-fibrotic factors (e.g., connective tissue growth factor, CTGF), but its relationship with the TGF-β1 pathway has not been systematically explored in pancreatic cancer (12, 13). This evidence concerns the gene CCN2 and pancreatic neoplasm.